198 related articles for article (PubMed ID: 28189215)
21. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
[TBL] [Abstract][Full Text] [Related]
22. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
23. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
24. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
Wang YZ; Xian JF; Wang XY; Guo J; Song LY
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
[No Abstract] [Full Text] [Related]
25. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of olfactory neuroblastomas from nasal squamous cell carcinomas using MR diffusion kurtosis imaging and dynamic contrast-enhanced MRI.
Xiao Z; Tang Z; Qiang J; Qian W; Zhong Y; Wang R; Wang J; Wu L; Tang W
J Magn Reson Imaging; 2018 Feb; 47(2):354-361. PubMed ID: 28661554
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of dynamic contrast enhancement combined with conventional MRI in differentiating benign and malignant lacrimal gland epithelial tumours.
Jian T; Yang M; Wu T; Ji X; Xia S; Sun F
Clin Radiol; 2024 Mar; 79(3):e345-e352. PubMed ID: 37953093
[TBL] [Abstract][Full Text] [Related]
29. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
Lang N; Su MY; Xing X; Yu HJ; Yuan H
J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
[TBL] [Abstract][Full Text] [Related]
30. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
[TBL] [Abstract][Full Text] [Related]
31. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced MRI versus
Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P
Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716
[TBL] [Abstract][Full Text] [Related]
33. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
35. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
Jena A; Mehta SB; Taneja S
J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
Lang N; Yuan H; Yu HJ; Su MY
Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
[TBL] [Abstract][Full Text] [Related]
37. Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions.
Lecler A; Balvay D; Cuenod CA; Marais L; Zmuda M; Sadik JC; Galatoire O; Farah E; El Methni J; Zuber K; Bergès O; Savatovsky J; Fournier L
J Magn Reson Imaging; 2019 Nov; 50(5):1514-1525. PubMed ID: 30989761
[TBL] [Abstract][Full Text] [Related]
38. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
Xu X; Wang P; Ma L; Shao Z; Zhang M
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
[TBL] [Abstract][Full Text] [Related]
39. Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI.
El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
Eur J Radiol; 2016 Nov; 85(11):2072-2082. PubMed ID: 27776661
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
